Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

253

HTML

2273

Figures (1-1)

135

Tables (1-1)

148

Sum=2809

Publishing Process of This Article

Item

Count

Browse

891

Download

855

Sum=1746

May 6, 2013 (publication date) through May 6, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Pharmacol Ther. May 6, 2013; 4(2): 23-27
Published online May 6, 2013. doi: 10.4292/wjgpt.v4.i2.23

Table 1 Comparison of side effects between the two regimens

¹Fisher’s exact test.

Citation: Gopal R, Elamurugan TP, Kate V, Jagdish S, Basu D. Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori. World J Gastrointest Pharmacol Ther 2013; 4(2): 23-27
URL: https://www.wjgnet.com/2150-5349/full/v4/i2/23.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v4.i2.23